FOX Translator
No data currently available.
No data currently available.
Even if you don't think you do, you already know plenty about commodities. Want us to prove it? No problem.
What makes oil produced in Saudi Arabia different from oil exported from Nigeria? It's the same thing that makes the corn you ate at last summer¿s barbecue different from the corn used to produce ethanol. Stumped? Well, don't feel bad, it's a trick question. The answer? Absolutely nothing. Corn is corn no matter where it comes from -- just as wheat is wheat and natural gas is -- right! -- natural gas. (Though the quality may differ, the make-up is uniform.)
So, in less elaborate terms, corn and oil (and all other commodities) are homogenous goods that can be processed, resold and more often than not, used as an input to the production of other goods or services. These goods are traded on a commodity exchange, thus setting the price-per-barrel (or other metric unit) used to value them.
Now pay attention, here's a question that indeed does have an answer: What is the difference between a commodity and a stock? While a stock can tank and become worthless, a commodity cannot have its value be wiped to zero. One other difference: Most commodities are traded in futures, meaning traders buy and sell where they think the price of a product will be at a certain point in the future. Stocks trade based on the value of the underlying company at that point in time.
Home
Wednesday, August 20, 2008
Positive Findings Published on Emergent Technology for Treating Chronic Pain
Comtex
PHILADELPHIA, Aug 20, 2008 /PRNewswire via COMTEX/ ----Peer-reviewed safety and efficacy data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)), successfully applied to patients suffering from treatment-resistant chronic pain appeared in the August/September issue of Electromyography and Clinical Neurophysiology. The findings reported by University of Pennsylvania associated physicians Jennifer Chu, M.D. and Ira Schwartz, M.D., Ph.D., represent an important advancement in understanding this debilitating disease.
"Seventy-six million Americans, including Olympic athletes suffer from constant long-standing muscle pain, for which treatment is elusive", says Dr. Chu, Associate Professor of Physical Medicine and Rehabilitation, and faculty at the University of Pennsylvania's Medical School for over 30 years. "This study demonstrates a ground-breaking, non-invasive and drug-free approach that controls and may ultimately eliminate the most common cause of muscle pain".
eToims(R)-related neuromuscular pain research began in 1990, combining 5,000-year-old art of acupuncture with modern technology applied to anatomical and neurophysiological science. In 2006, eToims(R) became non-invasive replacing needle use with a handheld electrical wand. eToims(R) produces muscle twitches by stimulating deep neuromuscular junctions at multiple body areas relieving muscle tightness, differentiating it from all other invasive and noninvasive neuromuscular stimulation.
The results were from 92 patients aged 20 to 82 years, with long standing, treatment non-responsive muscle pain, who paid for ongoing eToims(R) treatments. Pain relief was more definitive in those receiving 3Hz frequency electrical stimulation for 4 seconds than 1Hz for 1 second, establishing the therapeutic importance of low-frequency repetitive stimulation. There were no noted complications or adverse effects from weekly or bi-weekly treatments applied over 18 months.
Twitch-induced pain relief results from effective internal stretching of nerve-related, pain producing shortened muscles. The scientific deep massage effects relax muscles, release entrapped nerves, decrease traction on pain- sensitive structures, increase oxygen-rich blood inflow to, and pain-producing chemical outflow from affected areas.
eToims(R) Medical Technology, LLC developed and patented the eToims(R) system (www.stopmusclepain.com) and was recently named one of Philadelphia's Top 3 Emerging Biotechnology Companies by Benjamin Franklin Technology Partners. In September, the company will present at AdvaMed 2008: The MedTech Conference (www.advamed2008.com) in Washington D.C. eToims(R) Medical Technology is expected to receive relevant U.S. and European regulatory clearance before the end of 2008.
John Wannenburg RP&W (610)688-3164 john@robinsonpacker.com Jennifer Chu, M.D. eToims(R) Medical Technology (215)387-0550 jchu@etoims.com www.stopmusclepain.com
SOURCE eToims Medical Technology
http://www.stopmusclepain.com
Copyright (C) 2008 PR Newswire. All rights reserved
Market Snapshot
| Symbol | Last Price | Netchange | Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
| -- | -- | -- | -- |
FOX Business Tools
Sponsored By
